Lilly to Open $470M Pharmaceutical Manufacturing Plant

Drug maker Eli Lilly and Company is planning to open a new $470 million pharmaceutical manufacturing plant in Durham County, NC, the Economic Development Partnership of North Carolina (EDPNC) announced in a release Tuesday. 

Located in the Research Triangle Park, the site will produce injectable products and delivery devices. The company said it plans to hire over 400 highly skilled workers, including engineers and scientists. 

“This next generation manufacturing facility will allow us to expand our capacity to make Lilly medicines that are helping people with serious illnesses today, and help us prepare for new medicines coming from our robust pipeline in the future,” Lilly Chairman and Chief Executive Officer David A. Ricks said in a statement. “In the past two years, we have invested billions of capital in new U.S.-based manufacturing because the 2017 tax reform rebalanced the playing field in favor of the American worker.”

Click here for information about the upcoming International Powder & Bulk Solids Conference/Exhibition

Lilly announced a $400 million project last November to expand its manufacturing facilities at the Lilly Technology Center campus in Indianapolis, IN. The firm said it also will make improvements to its existing insulin production facilities, add capacity for the firm’s portfolio of diabetes-related medicines, and as a capital investment in medicines under development at the site.

The company made an $850 investment in its U.S. manufacturing operations in 2017, including an $85 million expansion of the firm’s Trulicity device assembly operations, upgrades to other existing sites, and the construction of a new facility.

For more news headlines, articles, and equipment reviews, visit our Equipment Zones

More Powder & Bulk Solids articles:

Chemical Activity Barometer Rose in January

Olam Creates Ingredients and Agribusiness Groups

BASF to Boost Methane Sulfonic Acid Capacity